Recall: American Health Lamivudine/Zidovudine Tablets Due to Dissolution Failure
American Health Packaging recalls specific lots of Lamivudine and Zidovudine tablets because they failed dissolution specifications. Check your medication details.
Use caution until it’s fixed
Failed dissolution specifications
Contact the company
What happened, in plain English
American Health Packaging is recalling Lamivudine and Zidovudine Tablets USP 150mg/300mg in 30-unit dose blisters due to failed dissolution specifications. This means the tablets may not release the drug into the body as intended, potentially affecting treatment efficacy. The recall affects 925 cartons distributed nationwide. Read more at govinfonow.com/recall/44911-american-health-packaging-recalls-lamivudine-and-zidovudine-tablets-usp-150mg.
Source Summary by GovInfoNow · govinfonow.com/recall/44911-american-health-packaging-recalls-lamivudine-and-zidovudine-tablets-usp-150mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-1140-2015
Cite this page
“Recall: American Health Lamivudine/Zidovudine Tablets Due to Dissolution Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44911-american-health-packaging-recalls-lamivudine-and-zidovudine-tablets-usp-150mg. Based on FDA recall #D-1140-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1140-2015%22&limit=1).
Why it’s dangerous
The tablets failed to meet dissolution specifications, which is a quality control measure ensuring the drug breaks down properly in the body. If the tablets do not dissolve correctly, the patient may not receive the full dose of the medication, potentially compromising their treatment plan.
Who’s affected
Patients currently taking Lamivudine and Zidovudine for HIV treatment who purchased the recalled product. Individuals with the specific lot number listed are at risk of receiving medication that may not work as expected.
How to tell if you have this one
Check your medication packaging for the brand American Health Packaging. Look for NDC 68084-0416-21 (Carton) or NDC 68084-0416-11 (Individual dose). Verify if the lot number is #140849.
- Brand
American Health Packaging- Category
Drug
What to do — step by step
Check Your Medication
Verify if your Lamivudine and Zidovudine tablets match the recalled NDC numbers and lot #140849.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider immediately to discuss alternative treatment options if you have the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other American Health Packaging recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1140-2015 (March 2, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1140-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.